Cwm, LLC Penumbra Inc Transaction History

Cwm, LLC

$28.4 Billion
Q2 2025

A detailed history of Cwm, LLC transactions in Penumbra Inc stock. As of the latest transaction made, Cwm, LLC holds 5,742 shares of PEN stock, worth $1.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,742

Previous 4,072 41.01%

Holding current value

$1.32 Million

Previous $1.09 Million 35.35%

% of portfolio

0.01%

Previous 0.0%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 25, 2025	BUY	$253.22 - $299.78 $422,877 - $500,632	1,670 Added 41.01%	5,742 $1.47 Million
Q1 2025 May 01, 2025	SELL	$237.28 - $303.76 $1.48 Million - $1.9 Million	-6,257 Reduced 60.58%	4,072 $1.09 Million
Q4 2024 Feb 04, 2025	BUY	$190.97 - $253.66 $1.59 Million - $2.11 Million	8,318 Added 413.63%	10,329 $2.45 Million
Q3 2024 Oct 08, 2024	BUY	$163.64 - $210.12 $75,438 - $96,865	461 Added 29.74%	2,011 $391,000
Q2 2024 Jul 09, 2024	BUY	$172.27 - $223.95 $182,433 - $237,163	1,059 Added 215.68%	1,550 $279,000
Q1 2024 Apr 05, 2024	SELL	$220.09 - $273.15 $4,401 - $5,463	-20 Reduced 3.91%	491 $110,000
Q4 2023 Feb 01, 2024	SELL	$181.44 - $260.22 $38,283 - $54,906	-211 Reduced 29.22%	511 $129,000
Q3 2023 Oct 11, 2023	SELL	$240.69 - $338.77 $107,107 - $150,752	-445 Reduced 38.13%	722 $175,000
Q2 2023 Aug 03, 2023	SELL	$271.54 - $344.06 $139,300 - $176,502	-513 Reduced 30.54%	1,167 $402,000
Q1 2023 Apr 28, 2023	SELL	$220.43 - $278.69 $37,473 - $47,377	-170 Reduced 9.19%	1,680 $468,000
Q4 2022 Feb 01, 2023	SELL	$151.88 - $228.5 $229,338 - $345,035	-1,510 Reduced 44.94%	1,850 $412,000
Q3 2022 Oct 27, 2022	SELL	$120.36 - $205.88 $35,746 - $61,146	-297 Reduced 8.12%	3,360 $637,000
Q2 2022 Jul 28, 2022	SELL	$116.09 - $227.33 $35,755 - $70,017	-308 Reduced 7.77%	3,657 $455,000
Q1 2022 Apr 21, 2022	SELL	$187.51 - $283.98 $195,572 - $296,191	-1,043 Reduced 20.83%	3,965 $881,000
Q4 2021 Jan 31, 2022	SELL	$238.08 - $288.0 $16,189 - $19,584	-68 Reduced 1.34%	5,008 $1.44 Million
Q1 2021 Sep 15, 2021	BUY	$175.6 - $291.43 $37,402 - $62,074	213 Added 4.38%	5,076 $1.39 Million
Q1 2021 Apr 27, 2021	SELL	$175.6 - $291.43 $37,402 - $62,074	-213 Reduced 4.2%	4,863 $1.32 Million
Q4 2020 Sep 15, 2021	BUY	$174.98 - $272.83 $231,148 - $360,408	1,321 Added 35.18%	5,076 $1.39 Million
Q4 2020 Jan 27, 2021	SELL	$174.98 - $272.83 $231,148 - $360,408	-1,321 Reduced 26.02%	3,755 $657,000
Q3 2020 Sep 15, 2021	BUY	$185.27 - $238.73 $940,430 - $1.21 Million	5,076 New	5,076 $1.39 Million
Q3 2020 Oct 19, 2020	SELL	$185.27 - $238.73 $940,430 - $1.21 Million	-5,076 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$153.32 - $191.72 $778,252 - $973,170	5,076 New	5,076 $1.39 Million
Q2 2020 Jul 22, 2020	SELL	$153.32 - $191.72 $778,252 - $973,170	-5,076 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$124.34 - $193.76 $631,149 - $983,525	5,076 New	5,076 $1.39 Million
Q1 2020 Apr 28, 2020	SELL	$124.34 - $193.76 $631,149 - $983,525	-5,076 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$134.81 - $177.8 $684,295 - $902,512	5,076 New	5,076 $1.39 Million
Q4 2019 Jan 27, 2020	SELL	$134.81 - $177.8 $684,295 - $902,512	-5,076 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$131.82 - $183.4 $665,427 - $925,803	5,048 Added 18028.57%	5,076 $1.39 Million
Q3 2019 Oct 22, 2019	SELL	$131.82 - $183.4 $665,427 - $925,803	-5,048 Reduced 99.45%	28 $4,000
Q2 2019 Sep 14, 2021	BUY	$124.65 - $167.39 $632,723 - $849,671	5,076 New	5,076 $1.39 Million
Q2 2019 Jul 31, 2019	SELL	$124.65 - $167.39 $632,723 - $849,671	-5,076 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$115.84 - $160.31 $588,003 - $813,733	5,076 New	5,076 $0
Q1 2019 Apr 22, 2019	SELL	$115.84 - $160.31 $347 - $480	-3 Closed	0 $0
Q4 2018 Jan 25, 2019	BUY	$113.42 - $156.48 $340 - $469	3 New	3 $0

Others Institutions Holding PEN

# of Institutions

479

Shares Held

28.8M

Call Options Held

352K

Put Options Held

66.7K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $8.72B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account